In conclusion, our findings demonstrate that PMN-MDSCs are capable of producing ETs upon stimulation with PRP from COVID-19 patients or with the SARS-CoV-2 Spike protein, through TLR4-independent and TLR4-dependent mechanisms, respectively. The gene discussed is TLR4; the disease is COVID-19.